
[ Fri, May 02nd ]: SpaceNews
[ Fri, May 02nd ]: Reuters
[ Fri, May 02nd ]: CNN
[ Fri, May 02nd ]: Forbes
[ Fri, May 02nd ]: BBC
[ Fri, May 02nd ]: ThePrint

[ Thu, May 01st ]: HuffPost
[ Thu, May 01st ]: WJZY
[ Thu, May 01st ]: Impacts
[ Thu, May 01st ]: BBC

[ Wed, Apr 30th ]: Artemis
[ Wed, Apr 30th ]: Devex
[ Wed, Apr 30th ]: HuffPost
[ Wed, Apr 30th ]: TheHealthSite
[ Wed, Apr 30th ]: PBS
[ Wed, Apr 30th ]: Forbes
[ Wed, Apr 30th ]: BBC

[ Tue, Apr 29th ]: WEAU
[ Tue, Apr 29th ]: SciTechDaily
[ Tue, Apr 29th ]: WTVY
[ Tue, Apr 29th ]: Forbes
[ Tue, Apr 29th ]: STAT
[ Tue, Apr 29th ]: TechCrunch
[ Tue, Apr 29th ]: CNN
[ Tue, Apr 29th ]: WGAL
[ Tue, Apr 29th ]: ABC
[ Tue, Apr 29th ]: BBC
[ Tue, Apr 29th ]: ThePrint

[ Mon, Apr 28th ]: Today
[ Mon, Apr 28th ]: Impacts
[ Mon, Apr 28th ]: news4sanantonio
[ Mon, Apr 28th ]: BBC
[ Mon, Apr 28th ]: STAT
[ Mon, Apr 28th ]: ThePrint
[ Mon, Apr 28th ]: Monitor
[ Mon, Apr 28th ]: Forbes

[ Sun, Apr 27th ]: CNN
[ Sun, Apr 27th ]: Forbes
[ Sun, Apr 27th ]: NDTV
[ Sun, Apr 27th ]: Daily
[ Sun, Apr 27th ]: BBC
[ Sun, Apr 27th ]: KXAN

[ Sat, Apr 26th ]: BBC
[ Sat, Apr 26th ]: CNN
[ Sat, Apr 26th ]: Daily

[ Fri, Apr 25th ]: ThePrint
[ Fri, Apr 25th ]: BBC
Uniqure gets FDA OK to seek accelerated approval


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I'm back from my

Read the Full STAT Article at:
[ https://www.statnews.com/2024/12/10/biotech-news-johnson-rfk-jr-pharma-lobbying-koneska-new-amsterdam-the-readout/ ]
Similar Science and Technology Publications
[ Sun, Apr 27th ]: Daily
[ Wed, Apr 16th ]: STAT
[ Tue, Apr 15th ]: STAT
[ Wed, Mar 26th ]: STAT
[ Tue, Mar 25th ]: Fortune
[ Fri, Mar 21st ]: PharmExec
[ Mon, Feb 10th ]: MSN
[ Tue, Jan 21st ]: STAT
[ Sun, Jan 19th ]: MSN
[ Sun, Jan 12th ]: MSN
[ Fri, Jan 10th ]: FierceBiotech
[ Mon, Dec 02nd 2024 ]: Tim Hastings